Cornercap Investment Counsel’s Astrana Health ASTH Stock Holding History
Bought
Maintained
Sold
Other funds holding ASTH
OAM
Cornercap Investment Counsel's ASTH Position: Q1 2022 in Review
Cornercap Investment Counsel sold out of Astrana Health (ASTH) in Q1 2022, closing a stake of 3,439 shares — an estimated $253K sold.
Cornercap Investment Counsel first reported a position in ASTH in Q1 2021 and held it in 4 quarters. The position peaked at $1.35M in Q1 2021. 139 funds tracked by Wall St. Rank hold ASTH as of Q1 2022.
- Cornercap Investment Counsel reported no remaining Astrana Health position as of Q1 2022 after selling out during the quarter.
- Cornercap Investment Counsel sold 3,439 Astrana Health shares in Q1 2022, an estimated $253K.
- Cornercap Investment Counsel first reported a position in Astrana Health in Q1 2021 and held it in 4 quarters.
- Cornercap Investment Counsel's Astrana Health position peaked at $1.35M in Q1 2021.
- 139 funds tracked by Wall St. Rank held Astrana Health as of Q1 2022.
Based on Cornercap Investment Counsel's 13F filing for Q1 2022, filed 10 May 2022.